Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non–small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching

Jie Nhan Liu^1-3, Tao Li⁴, Xiaohu Nhan Wang⁵, Shengfa Su^1,6, Qingsong Li^1,6, Yichao Geng^1,6, Wengang Yang^1,6, Xiaxia Chen^1,6, Weiwei Ouyang^1,6, Wei Zhang^1,2, Bing Lu^1,6

¹Department of Thoracic Oncology, Affiliated Hospital, Guizhou Medical University, Guiyang, Guizhou, China; ²Teaching and Research Section of Oncology, Guizhou Medical University, Guiyang, Guizhou, China; ³The Fourth People's Hospital of Guiyang, Guiyang, China; ⁴Sichuan Cancer Hospital and Institute, Sichuan, China; ⁵The First Clinical Medical College of Lanzhou University, Gansu Provincial Cancer Hospital, Guizhou, China; ⁶Affiliated Cancer Hospital of Guizhou Medical University, Guizhou, China.

For correspondence:- Bing Lu Email: lbgymaaaa@163.com

Accepted: 29 September 2022 Published: 30 November 2023

Citation: Liu JN, Li T, Wang XN, Su S, Li Q, Geng Y, et al. Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non–small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching. Trop J Pharm Res 2023; 22(11):2415-2415 doi: 10.4314/tjpr.v22i11.23

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

In the earlier published article, the affiliations of the first author were not completely provided. The correct affiliations are provided above.

New citation: Liu J, Li T, Wang X, Su S, Li Q, Yang W, et al. Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching. Trop J Pharm Res 2022; 21(10):2233-2240 doi: 10.4314/tjpr.v21i10.26 Erratum: 2023; 22(11): 2415 doi:10.4314/tjpr.v22i11.23

Earlier citation: Liu J, Li T, Wang X, Su S, Li Q, Yang W, et al. Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching. Trop J Pharm Res 2022; 21(10):2233-2240 doi: 10.4314/tjpr.v21i10.26

Keywords: Non-small-cell lung cancer, Volumetric-modulated arc therapy, Survival, Local progression-free survival, Radiation damage, Dose-volume parameter